mHealth推动新生儿黄疸筛查:墨西哥资源有限地区的混合方法随机对照可行性研究
该研究在墨西哥资源有限地区评估智能手机黄疸检测工具Picterus Jaundice Pro的可行性,采用混合方法随机对照可行性研究设计,纳入542名新生儿。结果显示干预组在阳性筛查比例、成功转诊、所需黄疸管理和实际接受黄疸管理方面均高于对照组,参与者认为工具易用且与工作流程整合良好;但11%病例因物流障碍和家长感知风险低而出现转诊不完整。
要点
- 干预组阳性筛查比例较对照组高0.299(95%CI 0.230至0.362)。
- 干预组成功转诊比例较对照组高0.112(95%CI 0.058至0.166)。
- 11%病例因物流障碍和家长感知风险低导致转诊不完整。
核心结论
- 实施Picterus Jaundice Pro在筛查实践方面取得了令人鼓舞的改善,凸显其推进新生儿护理的潜力。
- 解决系统性障碍并提高家长和医护人员的意识对于最大化影响至关重要。
研究设计与样本
- 采用混合方法,整合实用性随机对照试验(RCT)与半结构化访谈的定性洞察,均在可行性框架内进行。
- RCT中新生儿被随机分配至仅视觉评估筛查(对照组)或视觉评估加Picterus Jaundice Pro(干预组)。
- 2024年1月至6月共纳入542名新生儿(对照组273名,干预组269名)。
主要发现
- 与对照组相比,干预组阳性筛查比例差异为0.299(95%CI 0.230至0.362)。
- 与对照组相比,干预组成功转诊比例差异为0.112(95%CI 0.058至0.166)。
- 与对照组相比,干预组所需黄疸管理比例差异为0.045(95%CI 0.008至0.082)。
- 与对照组相比,干预组实际接受黄疸管理比例差异为0.038(95%CI 0.003至0.072)。
- 受访参与者认为Picterus Jaundice Pro用户友好且与工作流程整合良好。
关键数值与推荐
- 成功转诊至急诊室的胆红素标准为≥14.6 mg/dL(250 µmol/L)。
- 尽管协议依从性高,11%的病例因物流障碍和家长感知风险低而出现转诊不完整。
临床怎么用
- 在资源有限地区可考虑将智能手机黄疸检测工具整合入新生儿筛查流程以改善筛查实践。
- 需关注并解决转诊中的系统性物流障碍,同时提高家长和医护人员对新生儿黄疸风险的意识。
局限性
- 研究为可行性框架下的混合方法设计,样本来自墨西哥资源有限地区,外推需谨慎。
- 11%病例出现转诊不完整,提示实施中存在物流障碍和家长感知风险低的问题。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background Neonatal jaundice is a common and usually harmless condition, but 10% of cases can progress to severe forms that can cause irreversible brain damage or death if undetected and untreated. The prevalence of severe cases is higher in resource-limited settings due to limited access to reliable detection methods among other contributing factors. Objective To assess the feasibility of implementing Picterus Jaundice Pro, a smartphone-based detection tool for neonatal jaundice, in a resource-limited Mexican healthcare setting. Methods A mixed-methods approach was employed, integrating a pragmatic randomised controlled trial (RCT) with qualitative insights from semi-structured interviews, all conducted within a feasibility framework. In the RCT, newborns were randomly assigned to screening by visual assessment alone (control) or visual assessment plus Picterus Jaundice Pro (intervention). Feasibility outcomes included RCT-derived measures – the proportion of positive screenings, successful referrals to emergency room (bilirubin ≥14.6 mg/dL [250 µmol/L]), jaundice management needed and jaundice management received. Recruitment capability, device practicality, integration, acceptability and protocol adherence were also assessed. Results From January to June 2024, 542 newborns were included (273 control, 269 intervention). Compared with control, the intervention arm showed higher proportions (proportional difference [95% CI]) in positive screenings (0.299 [0.230 to 0.362]), successful referrals (0.112 [0.058 to 0.166]), jaundice management needed (0.045 [0.008 to 0.082]), and jaundice management received (0.038 [0.003 to 0.072]). Interviewed participants considered Picterus Jaundice Pro user-friendly and well-integrated into workflows. Despite high protocol adherence, incomplete referrals due to logistical barriers and low perceived risk by parents occurred in 11% of cases. Conclusions Implementing Picterus Jaundice Pro yielded encouraging improvements in screening practices, underscoring its potential to advance neonatal care. Addressing systemic barriers and raising awareness among parents and healthcare workers is crucial for maximizing impact. Trial registration number NCT06073444
引用
- BMJ Paediatrics Open:Advancing neonatal jaundice screening with mHealth: a mixed-methods randomised controlled feasibility study in a resource-limited setting in Mexico
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。